Rivian (RIVN) valuation

Run six valuation models on Rivian with live data: DCF, Reverse DCF, Graham number, Monte Carlo, scenarios and sum-of-the-parts (NAV).

RIVN
RIVN

Rivian

RIVN · Consumer Cyclical

Current price

12,11 USD

𝕏 Share on X
You're trying every model for free, no account needed. Sign up to save your analyses →

Valuation

Market cap
17.67 B USD
PE (TTM | NTM | +1y)
— | -6.87 | -5.20
Price / Sales
2.73
EV / EBITDA
-6.91
Price / Book
3.11

Cash flow

FCF yield(-1.51 / 12.11)
-12.44%
SBC-adjusted FCF yield(-2.07 / 12.11)
-17.12%
SBC impact
-37.58%

Margins & growth

Profit margin
-45.88%
Operating margin
-52.95%
Quarterly earnings (YoY)
-22.17%
Quarterly revenue (YoY)
+38.32%

Balance

Cash
5.50 B USD
Debt
5.43 B USD
Net position
71.00 M USD

Dividend

Dividend yield
0%
Payout ratio
—
Next payout
—

Price (5 years)

-90.56%
128.60 USD

What analysts expect

Consensus revenue and earnings per share for the periods not yet reported.

Revenue forecast

ReportedEstimate
01B2B3BQ4 25: 1.29 B USDQ4 25Q1 26: 1.38 B USDQ1 26Q2 26: 1.66 B USDQ2 26Q3 26: 2.16 B USDQ3 26Q4 26 · Estimate: 2.52 B USD (1.96 B USD – 2.73 B USD)Q4 26Q1 27 · Estimate: 2.52 B USD (1.34 B USD – 3.04 B USD)Q1 27USD

Consensus of 19 analysts for Q4 26 · +96.3% year on year

EPS forecast

ReportedEstimate
-0.75-0.5-0.250Q4 25: -0.66 · expected -0.79 (+16.65%)Q4 25Q1 26: -0.33 · expected -0.72 (+53.92%)Q1 26Q2 26: -0.63 · expected -0.78 (+18.85%)Q2 26Q3 26: -0.63 · expected -0.73 (+13.5%)Q3 26Q4 26 · Estimate: -0.67 (-0.71 – -0.51)Q4 26Q1 27 · Estimate: -0.63 (-0.90 – -0.40)Q1 27

Consensus of 12 analysts for Q4 26 · -1.09% year on year · adjusted earnings

Analyst consensus from Yahoo Finance. The dashed bar is the average and the whisker runs from the lowest analyst to the highest. On periods already reported, the green or red line marks what had been expected: below the bar means the company beat it. EPS is measured on an adjusted basis, which is what analysts forecast against and is not the accounting profit in the statements.

Revenue

estimate
01B2BQ4 20: 0.00 USDQ4 20Q1 21: 0.00 USDQ2 21: 0.00 USDQ3 21: 1.00 M USDQ4 21: 54.00 M USDQ4 21Q1 22: 95.00 M USDQ2 22: 364.00 M USDQ3 22: 536.00 M USDQ4 22: 663.00 M USDQ4 22Q1 23: 661.00 M USDQ2 23: 1.12 B USDQ3 23: 1.34 B USDQ4 23: 1.32 B USDQ4 23Q1 24: 1.20 B USDQ2 24: 1.16 B USDQ3 24: 874.00 M USDQ3 25: 1.56 B USDQ3 25Q4 25: 1.29 B USDQ1 26: 1.38 B USDQ2 26: 1.66 B USDQ3 26: 2.16 B USDQ3 26Q4 26 · estimate: 2.52 B USDQ4 26USD

EBITDA

-2B-1B0Q4 20: -341.00 M USDQ4 20Q1 21: -396.00 M USDQ2 21: -559.00 M USDQ3 21: -727.00 M USDQ4 21: -2.34 B USDQ4 21Q1 22: -1.46 B USDQ2 22: -1.55 B USDQ3 22: -1.60 B USDQ4 22: -1.60 B USDQ4 22Q1 23: -1.25 B USDQ2 23: -1.06 B USDQ3 23: -1.18 B USDQ4 23: -1.31 B USDQ4 23Q1 24: -1.20 B USDQ2 24: -1.10 B USDQ3 24: -910.00 M USDQ3 25: -911.00 M USDQ3 25Q4 25: -536.00 M USDQ1 26: -159.00 M USDQ2 26: -533.00 M USDQ3 26: -583.00 M USDQ3 26USD

Net income

-2B-1B0Q4 20: -353.00 M USDQ4 20Q1 21: -414.00 M USDQ2 21: -580.00 M USDQ3 21: -1.23 B USDQ4 21: -2.46 B USDQ4 21Q1 22: -1.59 B USDQ2 22: -1.71 B USDQ3 22: -1.72 B USDQ4 22: -1.72 B USDQ4 22Q1 23: -1.35 B USDQ2 23: -1.20 B USDQ3 23: -1.37 B USDQ4 23: -1.52 B USDQ4 23Q1 24: -1.45 B USDQ2 24: -1.46 B USDQ3 24: -1.10 B USDQ3 25: -1.17 B USDQ3 25Q4 25: -811.00 M USDQ1 26: -416.00 M USDQ2 26: -833.00 M USDQ3 26: -913.00 M USDQ3 26USD

Free cash flow

-2B-1B-500M0Q4 20: -577.00 M USDQ4 20Q1 21: -802.00 M USDQ2 21: -920.00 M USDQ3 21: -1.15 B USDQ4 21: -1.54 B USDQ4 21Q1 22: -1.45 B USDQ2 22: -1.56 B USDQ3 22: -1.67 B USDQ4 22: -1.74 B USDQ4 22Q1 23: -1.80 B USDQ2 23: -1.62 B USDQ3 23: -1.07 B USDQ4 23: -1.41 B USDQ4 23Q1 24: -1.52 B USDQ2 24: -1.04 B USDQ3 24: -1.15 B USDQ3 25: -421.00 M USDQ3 25Q4 25: -1.14 B USDQ1 26: -1.08 B USDQ2 26: -849.00 M USDQ3 26: -1.12 B USDQ3 26USD

EPS

-10-50Q4 20: -3.44Q4 20Q1 21: -4.10Q2 21: -5.74Q3 21: -12.21Q4 21: -0.93Q4 21Q1 22: -1.77Q2 22: -1.89Q3 22: -1.88Q4 22: -1.86Q4 22Q1 23: -1.45Q2 23: -1.27Q3 23: -1.44Q4 23: -1.58Q4 23Q1 24: -1.48Q2 24: -1.46Q3 24: -1.08Q3 25: -0.96Q3 25Q4 25: -0.66Q1 26: -0.33Q2 26: -0.63Q3 26: -0.63Q3 26

Cash & debt

CashDebt
05B10B15BQ4 20 · Cash: 2.98 B USDQ4 20Q3 21 · Cash: 5.16 B USDQ4 21 · Cash: 18.13 B USDQ1 22 · Cash: 16.43 B USDQ2 22 · Cash: 14.92 B USDQ2 22Q3 22 · Cash: 13.27 B USDQ4 22 · Cash: 11.57 B USDQ1 23 · Cash: 11.24 B USDQ2 23 · Cash: 9.26 B USDQ2 23Q3 23 · Cash: 7.94 B USDQ4 23 · Cash: 7.86 B USDQ1 24 · Cash: 5.98 B USDQ2 24 · Cash: 5.76 B USDQ2 24Q3 24 · Cash: 5.40 B USDQ3 25 · Cash: 4.44 B USDQ3 25 · Debt: 6.45 B USDQ4 25 · Cash: 3.58 B USDQ4 25 · Debt: 5.19 B USDQ1 26 · Cash: 2.85 B USDQ1 26 · Debt: 5.23 B USDQ2 26 · Cash: 3.59 B USDQ2 26 · Debt: 5.35 B USDQ3 26 · Cash: 3.51 B USDQ3 26 · Debt: 5.43 B USDQ3 26USD

Stock-based compensation

0200M400MQ1 21: 0.00 USDQ1 21Q2 21: 0.00 USDQ3 21: 0.00 USDQ4 21: 570.00 M USDQ1 22: 317.00 M USDQ1 22Q2 22: 242.00 M USDQ3 22: 293.00 M USDQ4 22: 135.00 M USDQ1 23: 183.00 M USDQ1 23Q2 23: 181.00 M USDQ3 23: 242.00 M USDQ4 23: 215.00 M USDQ1 24: 233.00 M USDQ1 24Q2 24: 194.00 M USDQ3 24: 111.00 M USDQ3 25: 174.00 M USDQ4 25: 190.00 M USDQ4 25Q1 26: 207.00 M USDQ2 26: 226.00 M USDQ3 26: 201.00 M USDQ3 26USD

Operating expenses

R&DSG&A
0500M1BQ4 20 · R&D: 255.00 M USDQ4 20 · SG&A: 98.00 M USDQ4 20Q1 21 · R&D: 289.00 M USDQ1 21 · SG&A: 121.00 M USDQ2 21 · R&D: 394.00 M USDQ2 21 · SG&A: 186.00 M USDQ3 21 · R&D: 441.00 M USDQ3 21 · SG&A: 253.00 M USDQ4 21 · R&D: 726.00 M USDQ4 21 · SG&A: 682.00 M USDQ4 21Q1 22 · R&D: 547.00 M USDQ1 22 · SG&A: 530.00 M USDQ2 22 · R&D: 543.00 M USDQ2 22 · SG&A: 461.00 M USDQ3 22 · R&D: 452.00 M USDQ3 22 · SG&A: 405.00 M USDQ4 22 · R&D: 402.00 M USDQ4 22 · SG&A: 393.00 M USDQ4 22Q1 23 · R&D: 496.00 M USDQ1 23 · SG&A: 402.00 M USDQ2 23 · R&D: 444.00 M USDQ2 23 · SG&A: 429.00 M USDQ3 23 · R&D: 529.00 M USDQ3 23 · SG&A: 434.00 M USDQ4 23 · R&D: 526.00 M USDQ4 23 · SG&A: 449.00 M USDQ4 23Q1 24 · R&D: 461.00 M USDQ1 24 · SG&A: 496.00 M USDQ2 24 · R&D: 428.00 M USDQ2 24 · SG&A: 496.00 M USDQ3 24 · R&D: 350.00 M USDQ3 24 · SG&A: 427.00 M USDQ3 25 · R&D: 453.00 M USDQ3 25 · SG&A: 554.00 M USDQ3 25Q4 25 · R&D: 424.00 M USDQ4 25 · SG&A: 308.00 M USDQ1 26 · R&D: 458.00 M USDQ1 26 · SG&A: 485.00 M USDQ2 26 · R&D: 466.00 M USDQ2 26 · SG&A: 485.00 M USDQ3 26 · R&D: 485.00 M USDQ3 26 · SG&A: 572.00 M USDQ3 26USD

Source: Yahoo Finance. Quarterly history grows automatically over time as new quarters are published.

Other comparisons

Popular companies